News

Congratulations to Leo Escano (Terry Fox Laboratory), for receiving a Canada Graduate Scholarships – Doctoral Program Award (CGS-D) from the Canadian Institutes of Health Research (CIHR).

The award is tied to his project titled, "Elucidating the mechanisms of immune escape in Cytogenetically Normal AMLs.”

The CIHR CGS-D provides special recognition and support to students who are pursuing a doctoral degree in a health-related field in Canada.

Please join us in congratulating Leo on this achievement!

Congratulations to Emily Yeh (Terry Fox Laboratory), for receiving a Canada Graduate Scholarships - Master's Award (CGS-M) from the Canadian Institutes of Health Research (CIHR).

The award is tied to her project titled, "Investigating contrasting germline mutations: SETD2 associated neurodevelopment syndromes", which looks at epigenetic dysregulation and transcriptional changes associated with two SETD2 neurodevelopmental syndromes in addition to modeling the mutations in cerebral organoids.

Researchers at BC Cancer and UBC have developed a new artificial intelligence (AI) model that can accurately predict if a person receiving cancer care will require mental health services during their treatment journey.

Dr. Cheryl Peters, a senior scientist in cancer prevention at BC Cancer and the BC Centre for Disease Control (BCCDC), is launching an exciting public health project called Combating online misinformation about cancer causes and prevention.
 

We are pleased to announce that Dr. Yongjin Park has been named Canada Research Chair in Integrative Causality Inference of Cancer Mechanisms (Tier 2).

A recent study published in the Journal of Clinical Investigation found that certain cancer-causing proteins can switch on parts of a person’s genetic material that were previously inactive, potentially contributing to the development and progression of Ewing sarcoma and prostate cancer. This finding helps researchers understand why the environment around a tumour may cause inflammation and suppress the immune system, which can make it challenging to successfully treat solid tumours with immunotherapy.